121 related articles for article (PubMed ID: 20149869)
1. Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging.
Goutayer M; Dufort S; Josserand V; Royère A; Heinrich E; Vinet F; Bibette J; Coll JL; Texier I
Eur J Pharm Biopharm; 2010 Jun; 75(2):137-47. PubMed ID: 20149869
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR dye: In vitro and in vivo evaluation.
Choi J; Rustique E; Henry M; Guidetti M; Josserand V; Sancey L; Boutet J; Coll JL
Int J Pharm; 2017 Nov; 532(2):677-685. PubMed ID: 28279737
[TBL] [Abstract][Full Text] [Related]
3. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.
Jin ZH; Josserand V; Foillard S; Boturyn D; Dumy P; Favrot MC; Coll JL
Mol Cancer; 2007 Jun; 6():41. PubMed ID: 17565663
[TBL] [Abstract][Full Text] [Related]
4. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY
Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795
[TBL] [Abstract][Full Text] [Related]
5. Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types.
Handgraaf HJM; Boonstra MC; Prevoo HAJM; Kuil J; Bordo MW; Boogerd LSF; Sibinga Mulder BG; Sier CFM; Vinkenburg-van Slooten ML; Valentijn ARPM; Burggraaf J; van de Velde CJH; Frangioni JV; Vahrmeijer AL
Oncotarget; 2017 Mar; 8(13):21054-21066. PubMed ID: 28416744
[TBL] [Abstract][Full Text] [Related]
6. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
[TBL] [Abstract][Full Text] [Related]
7. In vivo angiogenesis imaging of solid tumors by alpha(v)beta(3)-targeted, dual-modality micellar nanoprobes.
Kessinger CW; Khemtong C; Togao O; Takahashi M; Sumer BD; Gao J
Exp Biol Med (Maywood); 2010 Aug; 235(8):957-65. PubMed ID: 20660096
[TBL] [Abstract][Full Text] [Related]
8. Tumour targeting of lipid nanocapsules grafted with cRGD peptides.
Hirsjärvi S; Belloche C; Hindré F; Garcion E; Benoit JP
Eur J Pharm Biopharm; 2014 May; 87(1):152-9. PubMed ID: 24361535
[TBL] [Abstract][Full Text] [Related]
9. Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery.
Toti US; Guru BR; Grill AE; Panyam J
Mol Pharm; 2010 Aug; 7(4):1108-17. PubMed ID: 20527782
[TBL] [Abstract][Full Text] [Related]
10. Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins.
Morlieras J; Dufort S; Sancey L; Truillet C; Mignot A; Rossetti F; Dentamaro M; Laurent S; Vander Elst L; Muller RN; Antoine R; Dugourd P; Roux S; Perriat P; Lux F; Coll JL; Tillement O
Bioconjug Chem; 2013 Sep; 24(9):1584-97. PubMed ID: 23978076
[TBL] [Abstract][Full Text] [Related]
11. Comparative biodistribution in mice of cyanine dyes loaded in lipid nanoparticles.
Mérian J; Boisgard R; Bayle PA; Bardet M; Tavitian B; Texier I
Eur J Pharm Biopharm; 2015 Jun; 93():1-10. PubMed ID: 25805562
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4.
Jin ZH; Josserand V; Razkin J; Garanger E; Boturyn D; Favrot MC; Dumy P; Coll JL
Mol Imaging; 2006 Jul; 5(3):188-97. PubMed ID: 16954034
[TBL] [Abstract][Full Text] [Related]
13. New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors.
Garanger E; Boturyn D; Jin Z; Dumy P; Favrot MC; Coll JL
Mol Ther; 2005 Dec; 12(6):1168-75. PubMed ID: 16051524
[TBL] [Abstract][Full Text] [Related]
14. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting alphavbeta3 integrins.
Lesniak WG; Kariapper MS; Nair BM; Tan W; Hutson A; Balogh LP; Khan MK
Bioconjug Chem; 2007; 18(4):1148-54. PubMed ID: 17566976
[TBL] [Abstract][Full Text] [Related]
16. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
[TBL] [Abstract][Full Text] [Related]
18. Specific detection of integrin αvβ3 by light-up bioprobe with aggregation-induced emission characteristics.
Shi H; Liu J; Geng J; Tang BZ; Liu B
J Am Chem Soc; 2012 Jun; 134(23):9569-72. PubMed ID: 22642547
[TBL] [Abstract][Full Text] [Related]
19. [Development of siRNA Delivery Targeting the Tumor Microenvironment with a New Functional Device].
Sakurai Y
Yakugaku Zasshi; 2019; 139(11):1357-1363. PubMed ID: 31685731
[TBL] [Abstract][Full Text] [Related]
20. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
